GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (STU:MLZ) » Definitions » Net Margin %

MediPharm Labs (STU:MLZ) Net Margin % : -32.48% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is MediPharm Labs Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. MediPharm Labs's Net Income for the three months ended in Dec. 2023 was €-2.03 Mil. MediPharm Labs's Revenue for the three months ended in Dec. 2023 was €6.24 Mil. Therefore, MediPharm Labs's net margin for the quarter that ended in Dec. 2023 was -32.48%.

The historical rank and industry rank for MediPharm Labs's Net Margin % or its related term are showing as below:

STU:MLZ' s Net Margin % Range Over the Past 10 Years
Min: -252.41   Med: -135.57   Max: 1.27
Current: -39.57


STU:MLZ's Net Margin % is ranked worse than
78.31% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.53 vs STU:MLZ: -39.57

MediPharm Labs Net Margin % Historical Data

The historical data trend for MediPharm Labs's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Net Margin % Chart

MediPharm Labs Annual Data
Trend Sep17 Sep18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial 1.27 -184.25 -252.41 -135.57 -39.57

MediPharm Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -99.90 -52.86 -28.21 -50.87 -32.48

Competitive Comparison of MediPharm Labs's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediPharm Labs's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's Net Margin % distribution charts can be found below:

* The bar in red indicates where MediPharm Labs's Net Margin % falls into.



MediPharm Labs Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

MediPharm Labs's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-8.942/22.598
=-39.57 %

MediPharm Labs's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-2.027/6.241
=-32.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MediPharm Labs  (STU:MLZ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


MediPharm Labs Net Margin % Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


MediPharm Labs (STU:MLZ) Business Description

Traded in Other Exchanges
Address
151 John Street, Barrie, ON, CAN, L4N 2L1
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

MediPharm Labs (STU:MLZ) Headlines

No Headlines